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Oxidative stress within the arthritis joint has been indicated to be involved in generating mediators
for tissue degeneration and inﬂammation. COX-2 is a mediator in inﬂammatory action, pain and
some catabolic reactions in inﬂamed tissues. Here, we demonstrated a direct relationship between
oxidative stress and Cox-2 expression in the bovine synovial ﬁbroblasts. Furthermore, we elucidated
a novel mechanism, in which oxidative stress induced phosphorylation of MAPKs and NF-jB
through TAK1 activation and resulted in increased Cox-2 and prostaglandin E2 expression. Finally,
we demonstrated that ROS-induced Cox-2 expression was inhibited by supplementation of an
antioxidant such as N-acetyl cysteamine and hyaluronic acid in vitro and in vivo. From these results,
we conclude that oxidative stress is an important factor for generation of Cox-2 in synovial ﬁbrob-
lasts and thus its neutralization may be an effective strategy in palliative therapy for chronic joint
diseases.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Reactive oxygen species (ROS) produced by normal metabolism
are important biological mediators in the cellular signaling
cascades [1]. Appropriate amounts of ROS have beneﬁcial effects
on several physiological processes including protection from
pathogens, wound healing, and tissue regeneration [2,3]. On the
other hand, harmful levels of ROS could be generated in response
to ultraviolet radiation [4], cigarette smoking [5], alcohol [6], some
drugs [7,8], ischemia–reperfusion injury [9] and inﬂammatory
disorders [10]. Disproportionate levels of ROS give rise to further
disease development such as cardiovascular disease, neurodegen-
eration, cancer and chronic inﬂammation [3,5].
Oxidative stresses in the joint have been indicated as being
involved as inﬂammatory mediators in the arthritis [2,11].
Intra-articular ROS may be responsible for collagen hydrolysis
and activation of metalloproteinase, leading to the degradation of
the extracellular matrix in cartilage [12–15], and resulting in thepathogenesis of osteoarthritis (OA) [11,16,17]. Rheumatoid arthri-
tis (RA), which is an autoimmune inﬂammatory disease, is also
accompanied by oxidative stress that can directly contribute
toward the destructive, proliferative synovitis evident in RA [2,18].
In the chronic arthritis such as RA or OA, high levels of
cyclooxygenase (COX)-2 are detected [19,20]. There are two
isoforms of the COX enzymes: COX-1 is expressed constitutively
in most cells. COX-2, on the other hand, is dramatically
up-regulated by inﬂammation and contributes to producing
prostaglandins (PGs), which mediate a number of the characteristic
features of inﬂammation and reactions leading to the tissue
damage [21]. In the arthritis, localization of Cox-2 in vascular
endothelial cells, inﬁltrating mononuclear inﬂammatory cells,
and subsynovial ﬁbroblast-like cells are well observed [19]. Some
researchers have reported that inﬂammatory cytokines, such as
interleukin (IL)-1 and tumor necrosis factor (TNF)-a, and growth
factors, such as platelet-derived growth factor (PDGF), positively
regulate COX-2 expression. [22,23].
Interestingly, the relationship between ROS and Cox-2 has been
reported in the different cell types. Barbieri et al. elucidated that
Cox-2 expression could be triggered by ROS through activation of
NF-jB and ERK1/2 in macrophage [24]. Mari et al. demonstrated
that supplementation of antioxidants diminished IL-1a induced
Cox-2 expression in intestinal myoﬁbroblasts [22]. Unfavorable
ROS and/or Cox-2 are clearly important therapeutic targets for
chronic joint inﬂammation, thus elucidation of the relationship
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ing effective treatments.
The present study was designed to (i) evaluate the proﬁle of
Cox-2 expression after ROS addition in vitro, and (ii) understand
the mechanisms of how ROS enhance Cox-2 expression in synovial
ﬁbroblasts.
2. Materials and methods
2.1. Animal use and care
The use of animals complied with the regulations of the
Institutional Animal Use and Care Committee of the Kinki
University Faculty of Medicine. Each mouse was housed in an indi-
vidual pen with food and water ad libitum. Animals were exposed
to an artiﬁcially controlled light–dark regime with 14 h (hours)
lighting and 10 h darkness. Temperature was maintained between
20 C and 25 C in a ventilated room. All operations were per-
formed under anesthesia induced by abdominal cavity injection
of 50 mg/kg sodium pentobarbital and local injection of 2%
Xylocaine with epinephrine.
2.2. Culture of the synovial ﬁbroblast cells (SFs)
Synovial tissues were collected from the metacarpophalangeal
(MP) joints of freshly slaughtered calves about 10 months of age,
which were donated from a local slaughterhouse. The SFs were
isolated from the synovial tissues by enzymatic digestion with
2 mg/ml of collagenase (Wako Pure Chemical Industries, Osaka,
Japan) for 6 h at 37 C. After ﬁltration, cells were seeded in culture
plates and cultured in 10% FCS supplemented alpha-MEM at 37 C
and 5% CO2, 20% O2 for 48 h.
2.3. Reagents treatment
Prior to exposure of H2O2, the SFs were pre-cultured in
serum-free culture medium composed of serum-free culture med-
ium consisting of 0.1% bovine serum albumin (BSA, Sigma–Aldrich,
St. Louis, MO, USA), alpha-MEM (Life technologies Inc., Carlsbad,
CA, USA), 1% insulin-transferrin selenium (Life technologies) andTable 1
Primer sequences used for qRT-PCR in the present study.
Primer name Primer sequence (50–30)
Cox-2 F: ACAACAGAGTGTGTGATGTGC
R: TGCTGTACGTAGTCTTCAATCAC
Gapdh F: GTGAAGGTCGGAGTGAACG
R: TAAAAGCAGCCCTGGTGAC
Table 2
Primary antibodies used in the WB experiments.
Antibody Company
Phospho p38 (Thr180/Tyr182, #4511) Cell Signaling Technology
p38 (#9212) Cell Signaling Technology
Phospho Erk1/2 (Thr202/Tyr204, #9101) Cell Signaling Technology
Erk1/2 (#4695) Cell Signaling Technology
Phospho JNK1/2 (Thr183/Tyr185, #4668) Cell Signaling Technology
JNK1/2 (#9252) Cell Signaling Technology
COX-2 (#12282) Cell Signaling Technology
Phospho TAK1 (Thr184/187, #4531) Cell Signaling Technology
TAK1 (#4505) Cell Signaling Technology
I-kappa B alpha (sc-371) Santa Cruz Biotechnology
Gapdh (3C2) Abnova1% antibiotic/antimycotic solution (Life Technologies) for 24 h.
The SFs were cultured under these conditions for 24 h when the
following reagents were added; 100 lM H2O2 (Wako Pure
Chemical Industries), 10 lM p38MAPK speciﬁc inhibitor
SB203580 (Wako), 5 lM MEK/Erk speciﬁc inhibitor PD0325901
(Wako), 10 lM JNK speciﬁc inhibitor SB600125 (Wako), 10 lM
NF-jB speciﬁc inhibitor Bay 11-7082 (Sigma), 5 lM TAK1 speciﬁc
inhibitor 5Z-7-Oxozeaenol (Sigma), 2 mg/ml hyaluronic acid (HA)
(SUVENYL, approx. 1900 kDa, CHUGAI PHARMACEUTICAL CO.,
LTD., Tokyo, Japan), 100 lM N-Acetylcysteine (Nacalai teque,
Kyoto, Japan).
2.4. Measurement of intracellular reactive oxygen species (ROS)
Generation of ROS was detected using 30-p-(aminophenyl) ﬂuo-
rescein (APF) (Sekisui Medical CO. LTD., Tokyo, Japan) in vitro.
Bovine SFs at passage 2 were seeded on 6-well plate, and incubated
with 5 lM APF (ﬁnal concentration) for 30 min at 37 C. After
washing twice with culture medium, the cells were treated with
H2O2 with/without HA for 2 h. Then, the cells were dispersed by
TrypLE Express (Life Technologies), re-suspended with PBS and
put into 96-well black bottom assay plates (Corning, NY, USA).
Fluorescence intensities were analyzed by a Wallac ARVO MX
1420 multilabel counter (Perkin Elmer Japan, Kanagawa, Japan).
2.5. Quantitative RT-PCR (qRT-PCR) analysis
Total RNA was extracted with the TRIzol reagent (Invitrogen)
and reverse transcribed with the High Capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA, USA). The
qRT-PCR with total cDNA was performed using Perfect real-time
SYBR green II (Takara Bio, Inc., Shiga, Japan) with speciﬁc primers
(Table 1) in the Thermal Cycler Dice Real Time System (Takara
Bio, Inc.) at 95 C for 20 s followed by 40 cycles of 95 C for 5 s,
60 C for 30 s. To quantify the relative expression of each gene,
the Ct (threshold cycle) values were normalized to an endogenous
reference (DCt = Cttarget  CtGapdh) and compared with a calibrator
(control), using the DDCt method (DDCt =DCtsample  DCtcalibrator).
2.6. Western blot (WB) analysis
The SFs were lysed with the LIPA buffer and mixed with SDS
buffer (4% SDS, 125 mM Tris–HCl, 10% 2-mercaptoethanol, 0.01%
bromophenol blue in 20% glycerol), then the total cell lysates were
separated by SDS–PAGE and transferred to polyvinylidene diﬂuo-
ride (PVDF) membranes. (Hybond-P; Amersham Pharmacia
Biotech, Buckinghamshire, UK). The blotted membranes were
blocked at room temperature for 1 h with Block Ace (Dainippon
Pharmaceutical, Osaka, Japan) and treated with the following pri-
mary antibodies (Table 2) overnight at 4 C. Detection was realizedDilution Speciﬁc band (kDa)
1/3000 in Immuno-enhancer 38
1/5000 in Immuno-enhancer 38
1/3000 in Immuno-enhancer 42/44
1/5000 in Immuno-enhancer 42/44
1/1000 in Immuno-enhancer 46/54
1/1000 in Immuno-enhancer 46/54
1/5000 in Immuno-enhancer 74
1/1000 in Immuno-enhancer 82
1/1000 in Immuno-enhancer 82
1/1000 in Immuno-enhancer 35–41
1/10,000 in Immuno-enhancer 38
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and horseradish peroxidase (HRP)-conjugated secondary antibod-
ies (all were purchased from Santa Cruz Biotechnology, CA, USA)
corresponding to each primary antibody. The lumino-labeled
membranes were analyzed by the Amersham™ Imager 600 (GE
Healthcare, Tokyo, Japan).
2.7. Enzyme-linked immunosorbent assay (ELISA)
To estimate the PGE2 concentrations in the SFs, the samples
were lysed in 15% methanol in 0.1 M sodium phosphate bufferTable 3
Primary antibodies used in the immunohistochemistry.
Antibody Company Dilution
DNP(ROIK04) SHIMA
Laboratories
1/300 in 10% Block Ace/TBS-T
COX-2(#12282) Cell Signaling
Technology
1/300 in 10% Block Ace/TBS-T
Phospho TAK1(#4531) Cell Signaling
Technology
1/300 in 10% Block Ace/TBS-T
Fig. 1. H2O2 addition induced Cox-2 expression in SFs. (A) Estimation of intracellular RO
expression after H2O2 treatment. (C) Cox-2 protein expression in the H2O2-treated SF
dependent manner was detected by ELISA assay.(pH 7.5), centrifuged at 12,000 rpm for 5 min and then the super-
natant was collected. For each assay, 100 ll of the supernatant of
the lysates was added to a well of the 96-well ELISA plate from
the Human PGE2 ELISA kit (OXFORD BIOMEDICAL RESERCH, MI,
USA) and sequentially treated with detection antibodies and chro-
mogenic substrate according to the manufacturer’s instructions.
The reaction was terminated by adding 50 ll of 1 M H2SO4 to the
well, and the optical density was read at 450 nm. The PGE2
concentration was determined based on a standard curve that
was produced using the serially diluted reference samples
provided in the PGE2 ELISA kit.
2.8. Surgical OA model mice and drug treatment
Experimental OA was induced by surgical destabilization of the
medial meniscus (DMM), as described previously [25,26]. Only
8-weeks (wks) old female mice were used in our study. Under
anesthesia, the right knee joint capsule was exposed and the med-
ial meniscotibial ligament was transected under microscope to
give destabilization of the medial meniscus. A sham operation
was performed on the left knee joint in which the ligament wasS after H2O2 stimulation to the SFs by APF staining. (B) qPCR assay for Cox-2 mRNA
s shown by WB. (D) Increasing of PGE2 expression by H2O2 stimulation in dose
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received intra-articular injection of 20 ll of HA (SUVENYL,
CHUGAI PHARMACEUTICAL CO., LTD.) or the same volume of saline
as control. Four days after treatments, they were sacriﬁced and
used for the analysis.
2.9. Histology and ﬂuorescence microscopy
To observe the ROS accumulation, we used the Protein
Carbonyls Immunohistochemical Staining Kit (SHIMA
Laboratories, Co., LTD., Tokyo, Japan). Generated ROS in the cells
or tissues react with circumjacent protein and modiﬁed lysine,
arginine, proline, and threonine side chain amines into aminoacyl
carbonyls. Thus we can detect and quantify the accumulation of
ROS as the existence of the carbonylated protein [27].
Immunoﬂuorescence and histological analysis were performed
according to the manufacture’s instruction of a ProteinFig. 2. H2O2 addition induced Cox-2 and PGE2 expression through phosphorylation of MA
H2O2-treated SFs by WB. (B) qPCR assay for the Cox-2 expression in the SFs treated with
untreated control. (C) WB analysis for Cox-2 expressions in the SFs treated with H2O2 and
with H2O2 and MAPKs or NF-jB inhibitors. Y-axis shows staining intensity (absorbanceCarbonyls Immunohistochemical Staining Kit. The knee joints
were ﬁxed and decalciﬁed with decalcifying liquid K-CX
(FALMA, Tokyo, Japan). For histological observation, the samples
were dehydrated and embedded in parafﬁn. The sections were
then stained with Safranin-O (Sigma) or double-stained with
Alcian blue (Wako). The knee joints were deparafﬁnized and
rehydrated parafﬁn sections were blocked with Block Ace for
1 h, then washed twice with 0.1% Triton-TBS (TBS-T), and
incubated with 1/300 diluted each antibody (Table 3) at 4 C
overnight. The specimens were then washed twice with TBS-T
containing 10% Block Ace and incubated with 1/1000 diluted
FITC-conjugated anti-rabbit IgG bovine secondary antibody. After
two washes, 1/1000 diluted DAPI and observed using a ﬂuores-
cence microscope (BZ-9000, Keyence corporation, Osaka, Japan).
2,4-Dinitrophenol (DNP) and Cox-2 positive cells in the
cartilage-synovial junction were quantiﬁed by BZ-9000 software
(Keyence corporation).PKs and IkB in the SFs. (A) Detection of phosphorylated p38, JNK, Erk and IjB in the
H2O2 and MAPKs or NF-jB inhibitors. Y-axis shows relative expression values to the
MAPKs or NF-jB inhibitors. (D) ELISA assays for PGE2 expression in the SFs treated
) of each sample.
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Signiﬁcant difference was detected by Tukey–Kramer HSD test
or Student’s t-test. A p-value of less than 0.05 was considered
signiﬁcant.
3. Results
3.1. ROS induced expression of Cox-2 and PGE2 in the SFs
We ﬁrst determined if the ROS induced Cox-2 generation in the
SFs. H2O2 clearly increased intracellular ROS levels in a dose depen-
dent manner (Fig. 1A). Similarly, qRT-PCR revealed that the Cox-2
mRNA expression increased depending on the concentration of
H2O2 (Fig. 1B). To conﬁrm the expression of Cox-2 in protein levels,
we performedWB assay and observed signiﬁcant increase of Cox-2
proteins when the cells were stimulated by H2O2 at 50 lM and
100 lM (Fig. 1C). We then performed ELISA assay for PGE2 down-
stream molecule of Cox-2. The results were consistent with ELISA,
in which signiﬁcant up-regulation of PGE2 (Fig. 1D).Fig. 3. TAK1 is involved in H2O2 mediated activation of MAPKs and NF-jB signaling cas
treated with H2O2 and TAK1 inhibitor. (B) pPCR analysis for Cox-2 expression in the cell
H2O2 stimulation and TAK1 inhibition. (D) ELISA analysis for PGE2 expression after H2O3.2. MAPKs and NF-jB activities potentially mediated ROS induced
Cox-2 and PGE2 up-regulation
Previous studies demonstrated that MAPKs and/or NF-jB could
be the second messenger in the ROS-induced signaling pathways in
macrophage [24]. Thus we hypothesized that the MAPKs and/or
NF-jB play an important role for the ROS- induced Cox-2 expres-
sion also in the SFs. After stimulation of the SFs by 100 lM of
H2O2, clear enhancement in phosphorylated p38, JNK, Erk and
IjB, which is a marker for NF-jB activity, were detected by WB
analysis (Fig. 2A). To conﬁrm if the phosphorylated status of
MAPKs and NF-jB relates to Cox-2 and subsequent PGE2 expres-
sions, we treated the SFs by H2O2 with MAPKs or NF-jB inhibitors
followed by examined Cox-2 and PGE2 expressions. When the
SFs were treated by H2O2 in the presence of p38 inhibitors,
H2O2-enhanced Cox-2 expression was abolished. Similarly, ERK
or NF-jB inhibitors also signiﬁcantly attenuated H2O2-enhanced
Cox-2 expression, respectively. On the other hand, JNK inhibitor
did not show any effect on the ROS-induced Cox-2 expression
(Fig. 2B). These results were veriﬁed by WB analysis: Cox-2 proteincades. (A) WB analysis for the phosphorylated status of MAPKs and IjB in the cells
s treated with H2O2 and TAK1 inhibitor. (C) WB analysis for Cox-2 expression after
2 stimulation and TAK1 inhibition.
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or NF-jB inhibitors (Fig. 2C). Then we conﬁrmed that the alteration
in the Cox-2 expression was reﬂected into the downstream PGE2
by ELISA assay. The ELISA assay clearly showed similar trend with
that of Cox-2: H2O2 addition induced about 2.2 times increase in
the PGE2 protein, and p38, ERK and NF-jB inhibitors attenuated
the expression levels to the baseline control, respectively (Fig. 2D).
3.3. TAK1 mediated H2O2-indiced MAPKs and NF-jB activations
Since multiple MAPKs and NF-jB were simultaneously acti-
vated by ROS, we hypothesized that some upstream molecules
were responsible for the ROS-induced up-regulation of Cox-2 and
PGE2 expressions. Accumulating evidence suggests the involve-
ment of TAK1 in the ROS-induced MAPKs activation [28,29]. Thus
we looked at the effect of H2O2 in the phosphorylation of TAK1
and found that H2O2 clearly caused the phosphorylation of TAK1
in the SFs. Supplementation of TAK1 inhibitor blocked phosphory-
lation of the downstream molecules p38, Erk and NF-jB, respec-
tively (Fig. 3A). Importantly, Inhibition of TAK1 during H2O2Fig. 4. Antioxidants attenuate ROS-mediated Cox2 and PGE2 expressions. (A) Estimation
NAC or 2 mg/ml HA. (B) qPCR analysis for Cox-2 expression in the SFs treated with H2O2 a
phosphorylation and Cox2 expression in the cells treated with NAC and HA. (D) ELISA a
2 mg/ml HA.treatment blocked both the expression of Cox-2 and PGE2 com-
pletely on RNA (Fig. 3B) and protein levels (Fig. 3C and D). This
action was conserved in other cell types (Supplement 1).
3.4. Supplementation of N-acetyl cysteamine (NAC) and hyaluronic
acid (HA) resulted in repression of Cox-2 and PGE2 expressions
As the last part of the study, we examined if the supplementa-
tion of antioxidant could suppress the ROS-induced Cox-2
expression both in vitro and in vivo. When we treated the SFs with
H2O2 and NAC, which is a potent ROS scavenger due to its cysteine
residues, accumulation of intracellular ROS was blocked (Fig. 4A).
HA is also a potent ROS scavengers [30,31]. Importantly, phospho-
rylation of TAK1 was inhibited in both NAC and HA-added condi-
tions (Fig. 4B) and Cox-2 expression was repressed to the similar
level with that of the baseline control by treatment with the
antioxidants (Fig. 4C). Then we observed PGE2 expression in
H2O2 and HA or NAC treated cells by ELISA. The ELISA assay clearly
showed that the expression of PGE2 was also signiﬁcantly
attenuated in HA or NAC-treated cells (Fig. 4D). Finally, we triedof the intracellular ROS levels in the cells treated with 100 lM H2O2 and 100 lM
nd 100 lMNAC or HA at 0.5, 1, 2 and 5 mg/ml. (C) WB showing suppression of TAK1
ssays for PGE2 expression in the SFs treated with 100 lM H2O2, 100 lM NAC and
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surgical OA models, which has signiﬁcant synovial expansion and
inﬂammation.
In the joint of the DMM-induced OA model mice, clear synovial
thickening was observed at 4 wks after surgery (Fig. 5A). In the
lesions, strong DNP signals reﬂecting accumulation of the
ROS-dependent carbonylated protein was detected. Furthermore,
expression of phosphorylated TAK1 and Cox-2 were observed. In
the OA mice injected with HA, ROS-derived protein carbonylation,Fig. 5. Intra-articular injection of HA attenuated ROS accumulation and Cox-2 expressio
staining from sham, DMM, and DMM joint treated with HA. F: Femur, T: Tibia, Me: M
immunoﬂuorescence for the DNP, phosphorylated TAK1 and Cox-2. Different charactersdetected with the DNP expression, was attenuated (Supplement
Fig. 3) although thickness of the synovial tissue was not affected
(data not shown). Both phosphorylated TAK1 and Cox-2 expression
were also completely inhibited (Fig. 5B).
4. Discussion
Here we described the relationship between ROS and Cox-2
expression in the SFs and explored a mechanism: ROS activatesn in the surgical OA mice. (A) Triplicate sections with hematoxylin and eosin (HE)
eniscus, Syn: Synovia, M: Muscle. Scale bar = 200 lm. (B) Quantiﬁed expression of
mean signiﬁcant differences between each group.
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Cox-2 expression and PGE2 production.
In the present study we ﬁrst demonstrated that the ROS
induced Cox-2 expression in the SFs. Some previous studies have
shown that Cox-2 expression is regulated by MAPKs (p38, ERK,
etc) and NF-jB [32–34]. These MAPKs or NF-jB control the
Cox-2 expression through directly binding to the promoter region
of Cox-2 or via regulation of other transcription factors [35–38].
Furthermore the activated MAPKs and NF-jB can induce produc-
tion of inﬂammatory cytokines [39,40] that strongly induce various
catabolic factors. In the present study, we demonstrated that the
activations of the p38, ERK and NF-jB directly link to the expres-
sion level of Cox-2, consistent with the previous report [41]. On
the other hand, we observed that the inhibition of JNK activity,
in turn, further enhanced H2O2-induced Cox-2 expression. In gen-
eral, the function of JNK is closely linked with the Cox-2 genera-
tion, but JNK does not contribute to the stress-induced Cox-2
expression cascades [38,42,43], probably it depends on the cell
and stress types loaded on the cells. We also conﬁrmed that ROS
stimulation induced phosphorylation of MAPKs and NF-jB in the
SFs. Until now, there have been some papers suggesting the rela-
tionship between ROS accumulation and MAPK activation. In terms
of the chondrocytes, the enhanced p38 phosphorylation with ROS
has been reported [44]. Phosphorylations of ERK, JNK and NF-jB
by ROS also have been described in various cell types [34,45,46].
These studies support the validity of our observation that ROS
activated MAPKs and NF-jB in the SFs, and provide evidence that
both MAPKs and NF-jB activations have important roles for the
ROS-induced Cox-2 expression.
Furthermore, we hypothesized that ROS targets a common
molecule located at upstream of both MAPKs and NF-jB. In this
study, we focused on a candidate molecule TAK1, which could be
a common upstream regulator of MAPKs and NF-jB [47–49].
Sato et al. demonstrated that IL-1b and TNFa caused phosphoryla-
tion of IjB and subsequent NF-jB activation, phosphorylation and
activation of JNK and p38, leading to the impairment in embryonic
ﬁbroblast cells of TAK1 KO mouse [48]. This evidence clearly sug-
gests that TAK1 is a critical regulator of both MAPKs and NF-jB.
We actually demonstrated here that ROS induced TAK1 phospho-
rylation and subsequent Cox-2 expression. Furthermore, we
observed that inhibition of TAK1 phosphorylation attenuated
MAPK and NF-kB activation and also resulted in complete suppres-
sion of Cox-2 and PGE2 expressions. In terms of TAK1 induction by
intracellular ROS generation, Wang et al. demonstrated in a pan-
creatic cancer cell with an anticancer drug Belinostat [29]. They
observed that ROS generated by Belinostat induced TAK1 activa-
tion and resulted in AMPK-induced cell death. Chen et al. also
reported that TAK1 activation occurred in H2O2 treated cardiomy-
ocytes [28]. We demonstrated here that TAK1 was a primary effec-
tor molecule for ROS in normal cells, and the pathway from TAK1
activation to Cox-2 expression through MAPKs/NF-jB activations
were signiﬁcant target pathway for treatments of ROS-induced
inﬂammation and pain. Contrarily, Hammaker et al. reported that
decreasing the TAK1 expression did not affect the phosphorylation
of p38 in the IL-1b treated synovial cells [50]. TAK1 binds to TAK1
binding proteins and other cofactors, and form TAK-1 complex to
transduce stress signaling to MAPKs [51,52]. Thus it is possible that
cofactors contribute to the variation of the reaction against IL-1
and ROS, although its precise role has to be elucidated.
Since ROS was a direct causative agent for Cox-2 expression and
subsequent PGE2 production in the SFs, we then tested supple-
mentation of ROS scavengers and examined if removing ROS can
quench down the action of TAK1-MAPKs/Nf-kB-Cox2 and PGE2
cascades. We used two anti-ROS agent in this study; NAC, which
is a by-product of glutathione and is popular as a potent scavenger
of ROS due to its cysteine residues. HA, which is also a potentialredox therapeutic molecule in the arthritic joint [30]. Underlying
antioxidant mechanism of HA is due to chelation potentials of tran-
sition metals ions like Cu2+ or Fe2+, in which they lead to radical
generation [31]. Addition of both NAC and HA attenuated ROS
induced TAK1 phosphorylation and subsequent Cox-2 and PGE2
expressions in the SFs. These results may be an independent evi-
dence for the idea that ROS directly induce TAK1 activation,
MAPKs/NF-jB phosphorylation and subsequent Cox-2 and PGE2
expression. Finally, we performed intra-articular HA injection into
the DMM model mice, and examined if the neutralization of
OA-derived ROS can attenuate Cox-2 expression in vivo. As a result,
HA injection into the joint clearly suppressed not only ROS accu-
mulation but also Cox-2 generation. This result was consistent
with the in vitro data, in which HA can suppress Cox-2 expression
[53]. On the other hand, there are some papers showing that addi-
tion of HA resulted in up-regulation of Cox-2 in cancer cells or
ﬁbroblast cells [54–56]. One of the possible explanation is the
phenotypic differences in the used cells, since HA plays a pivotal
biological effect depending on the molecular weight [57].
Actually, inhibitory redox and Cox-2 effect was reported using
high-molecular weight HA (HMW-HA) [58,59]. Furthermore, it
has also been well known that p38 is phosphorylated by ROS and
HMW-HA can attenuate its effect [60–62]. Contrarily, low-
molecular weight HA (LMW-HA) induces MAPKs phosphorylation
and subsequent Cox-2 expression [63,64]. Although further
research will be necessary to elucidate the mechanisms,
HMW-HA used in this study clearly suppressed ROS-induced p38
activation and Cox-2 expression.
Clinically, Cox-2 is believed to be a crucial therapeutic target
because COX-2 contributes to the induction of PGE2 and other
catabolic factors [20,65,66]. However, numerous studies suggest
the negative side effect of the Cox2 inhibitors. On the other hand,
development of antioxidant to reduce the ROS accumulations,
which could be an essential factor for some chronic situations,
has been an attractive research ﬁeld. Actually, recent research sug-
gested some signiﬁcance of antioxidant in the treatment of
arthritis.
In conclusion, we demonstrated a functional link between ROS
and TAK1-MAPKs/NF-jB-Cox2-PGE2. This mechanism could be
considered as a strategy to prevent arthritis.
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